For the past three weeks we have given you a powerpoint presentation on changes in provider care, especially ACOs and PCHMs. During this time we have been discussing the way that these care models are being built and the goals they are striving for. This week in Part 4 we …

Week after week it seems like old myths about diabetes, lipidemia and hypertension are falling by the wayside. For years we focused on calories and sugar and never made an effort to limit carbohydrates. In fact it has only been in the past five years that the ADA has even …

"Make The Link" Diabetes and Coronary Artery Disease Toolkit  The ADA has released a new resource for physicians: the "Make the Link" Diabetes and Coronary Artery Disease Resource Toolkit for Health Care Professionals. Research shows that people with diabetes are at increased risk for coronary artery disease (CAD) and have …

The Eocene System  A comprehensive disease management system specializing in the monitoring of patients with diabetes. The Remote Home Companion collects data from devices such as Glucometers, BP Cuffs and scales and displays the data from these devices in ways that enables healthcare providers to better manage patients. It eliminates …

In new-onset type 1 diabetes, hybrid closed-loop control (HCLC) followed by sensor-augmented pump (SAP) therapy did not provide benefit in preserving beta-cell function compared with current standards of care. Diabetes Care Oct 2013 

Data presented at the American Society for Bone and Mineral Research meeting showed older women with type 2 diabetes had lower trabecular bone score and 25-hydroxyvitamin D levels and higher bone alkaline phosphatase levels compared with controls. "We found that the trabecular bone score was worse in the patients with …

MannKind again filed an application with the FDA for approval to market its Afrezza inhalation powder, a fast mealtime insulin treatment intended to improve glycemic control for diabetes patients. The application was based on data from two late-stage trials. Mannkind Press Release Oct 2013 

Even people who didn’t have type 2 diabetes but had blood sugar at the high end of the normal range performed worse on memory tests….

Risk of progression more than doubled….

Phentermine and topiramate extended release combination drug reduces T2DM incidences….